Please assess the completion status of the following clinical trial:

Trial Title: A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of rheumatoid arthritis for at least 3 months and less than or equal to 3 years before screening~* Active disease at the time of screening and pre-infusion of the drug~Exclusion Criteria:~* Pregnant, nursing, or planning a pregnancy within 18 months of enrollment~* Incapacitated, largely or wholly bedridden, or confined to a wheelchair, or had little or no ability for self care~* Rheumatic disease other than rheumatoid arthritis or any current systemic inflammatory condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).